Because liver cells (hepatocytes) cannot be grown in the laboratory, researching liver disorders is extremely difficult.

因为肝细胞无法在实验室中培养，所以研究肝病特别困难。

Liver disorders include jaundice, hepatitis, cirrhosis, tumours, vascular obstruction, abscess, and glycogen-storage diseases.

肝病包括黄疸、肝炎、肝硬化、肿瘤、血管阻塞、脓疮和肝糖贮积病。

Products obtained by this method form a further aspect of the invention, and are useful in the treatment or prevention of diseases associated with liver disorders.

由本发明进一步方面的方法得到的产品，以及在治疗和预防与肝脏病症有关的疾病中的用途。

The PT, PTR and INR of 60 patients treated with oral anticoagulants and 40 patients with liver disorders were determined with the two kinds of thromboplastin reagents.

用进口试剂和自制品测定60例口服华法令抗凝治疗病人和40例肝病患者的PT，求得ptr和INR并进行比较。

Disease recurrence was most common in patients with underlying immune-mediated disorders of the liver.

原发病复发最常见于存在免疫应答介导的肝功能紊乱的患者。